Evidence map›Paper›PMID 29704626›Full record

ReviewInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2018

Understanding dengue virus evolution to support epidemic surveillance and counter-measure development.

S Pollett, M C Melendrez, I Maljkovic Berry, S Duchêne, H Salje, D A T Cummings, R G Jarman

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Insecticidal Potential ofPlants (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

S PollettViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Marie Bashir Institute, University of Sydney, NSW, Australia; Institute for Global Health Sciences, University of California at San Francisco, CA, USA. Electronic address: simon.d.pollett.ctr@mail.mil.
M C MelendrezViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
I Maljkovic BerryViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
S DuchêneDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Australia.
H SaljeInstitut Pasteur, Paris, France; Johns Hopkins School of Public Health, Baltimore, MD, USA.
D A T CummingsJohns Hopkins School of Public Health, Baltimore, MD, USA; University of Florida, FL, USA.
R G JarmanViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Walter Reed Army Institute of Research · USJohns Hopkins University · USUniversity of Melbourne · AU

Funding

LINKING ANTIGENIC & GENETIC VARIATION OF DENGUE TO INDIVIDUAL AND POPULATION RISKR01AI114703 · NIAID · UNIVERSITY OF FLORIDA · PI CUMMINGS, DEREK A · 2015 to 2019
$3.6M
NIAID NIH HHS R01 AI114703
6 · The paper itself

Abstract

Dengue virus (DENV) causes a profound burden of morbidity and mortality, and its global burden is rising due to the co-circulation of four divergent DENV serotypes in the ecological context of globalization, travel, climate change, urbanization, and expansion of the geographic range of the Ae.aegypti and Ae.albopictus vectors. Understanding DENV evolution offers valuable opportunities to enhance surveillance and response to DENV epidemics via advances in RNA virus sequencing, bioinformatics, phylogenetic and other computational biology methods. Here we provide a scoping overview of the evolution and molecular epidemiology of DENV and the range of ways that evolutionary analyses can be applied as a public health tool against this arboviral pathogen.

Indexed as

Biological EvolutionEpidemicsDengueDengue VirusHumansPopulation SurveillanceDengue virusEvolutionMolecular epidemiologyPhylogenetics

Identifiers

PMID29704626
PMCPMC6396301
OpenAlexW2802502040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.